Literature DB >> 9285436

EEG and evoked potentials in infantile neuronal ceroid-lipofuscinosis.

S L Vanhanen1, K Sainio, M Lappi, P Santavuori.   

Abstract

Sixteen children with infantile neuronal ceroid-lipofuscinosis (INCL), age range 0.5 to 5.4 years, were studied using EEG, electroretinograms (ERG), visual evoked potentials (VEP) and somatosensory evoked potentials (SEP). Electroencephalography was the first of these examinations to reveal abnormalities, however the EEG may be normal at the preclinical stage. The first abnormality to appear was an attenuated reaction to passive eye opening and closing which was followed by disturbances in background activity and diminution in amplitude, and by disappearance of sleep spindles. The gradual disappearance of posterior rhythm reactivity and of sleep spindles suggests that thalamic dysfunction progresses with time. EEG inactivity appeared by the age of 3 years. Evoked potentials were normal in the early stages of the disease. SEP showed abnormalities at Stage 2 (1.7 years), while ERG and VEP abnormalities appeared at Stage 3 (by the age of 2.5 years). All neurophysiological reactions examined were abolished by the age of 4 years. Follow-up EEG gives important hints as to the early diagnosis of INCL. Progression of the disease can be followed by evoked potentials which may also be helpful in the differential diagnostics.

Entities:  

Mesh:

Year:  1997        PMID: 9285436     DOI: 10.1111/j.1469-8749.1997.tb07465.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  10 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis.

Authors:  Marie S Roberts; Shannon L Macauley; Andrew M Wong; Denis Yilmas; Sarah Hohm; Jonathan D Cooper; Mark S Sands
Journal:  J Inherit Metab Dis       Date:  2012-02-07       Impact factor: 4.982

3.  Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.

Authors:  Catherine Kielar; Lucy Maddox; Ellen Bible; Charlie C Pontikis; Shannon L Macauley; Megan A Griffey; Michael Wong; Mark S Sands; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2006-10-12       Impact factor: 5.996

4.  MRI Brain Volume Measurements in Infantile Neuronal Ceroid Lipofuscinosis.

Authors:  E H Baker; S W Levin; Z Zhang; A B Mukherjee
Journal:  AJNR Am J Neuroradiol       Date:  2016-10-20       Impact factor: 3.825

5.  Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study.

Authors:  Sondra W Levin; Eva H Baker; Wadih M Zein; Zhongjian Zhang; Zenaide M N Quezado; Ning Miao; Andrea Gropman; Kurt J Griffin; Simona Bianconi; Goutam Chandra; Omar I Khan; Rafael C Caruso; Aiyi Liu; Anil B Mukherjee
Journal:  Lancet Neurol       Date:  2014-07-02       Impact factor: 44.182

6.  Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse.

Authors:  Shannon L Macauley; David F Wozniak; Catherine Kielar; Yun Tan; Jonathan D Cooper; Mark S Sands
Journal:  Exp Neurol       Date:  2009-02-10       Impact factor: 5.330

Review 7.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

Review 8.  Neuronal Ceroid Lipofuscinosis: The Multifaceted Approach to the Clinical Issues, an Overview.

Authors:  Alessandro Simonati; Ruth E Williams
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

9.  Novel CLN1 mutation with atypical juvenile neuronal ceroid lipofuscinosis.

Authors:  Arif Khan; Kwong S Chieng; Aravindhan Baheerathan; Nahin Hussain; Jayprakash Gosalakkal
Journal:  J Pediatr Neurosci       Date:  2013-01

10.  Evaluation of disease progression in INCL by MR spectroscopy.

Authors:  Eva H Baker; Sondra W Levin; Zhongjian Zhang; Anil B Mukherjee
Journal:  Ann Clin Transl Neurol       Date:  2015-07-01       Impact factor: 4.511

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.